Showing 1 – 10 of 10
Relevance | Newest | Oldest |
  • JAMA Original Investigation
    April 6, 2024

    Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial

    Richard M.听Martin,聽BM, BS, PhD; Emma L.听Turner,聽PhD; Grace J.听Young,聽MSc; Chris聽Metcalfe,聽PhD; Eleanor I.听Walsh,聽MSc; J. Athene聽Lane,聽PhD; Jonathan A. C.听Sterne,聽PhD; Sian聽Noble,聽PhD; Peter聽Holding,聽MSc; Yoav聽Ben-Shlomo,聽MBBS, PhD; Naomi J.听Williams,聽PhD; Nora聽Pashayan,听惭顿, PhD; Mai Ngoc聽Bui,聽PhD; Peter C.听Albertsen,听惭顿; Tyler M.听Seibert,听惭顿, PhD; Anthony L.听Zietman,听惭顿; Jon聽Oxley,听惭顿; Jan聽Adolfsson,听惭顿; Malcolm D.听Mason,听惭顿; George聽Davey Smith,聽DSc; David E.听Neal,听惭顿; Freddie C.听Hamdy,听惭顿; Jenny L.听Donovan,聽PhD; CAP Trial Group
    Abstract Full Text
    free access is active quiz has multimedia
    JAMA. 2024; 331(17):1460-1470. 10.1001/jama.2024.4011

    This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.

  • 榴莲视频 Network Open Original Investigation Oncology
    November 16, 2022

    Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy

    Anthony M.听Magliocco,听惭顿; Jennifer聽Moughan,聽MS; David T.听Miyamoto,听惭顿, PhD; Jeff聽Simko,听惭顿, PhD; William U.听Shipley,听惭顿; Phillip J.听Gray,听惭顿; Michael P.听Hagan,听惭顿; Matthew聽Parliament,听惭顿; William J.听Tester,听惭顿; Anthony L.听Zietman,听惭顿; Susan聽McCarthy,聽MSc; Daryoush聽Saeed-Vafa,听惭顿; Yin聽Xiong,聽PhD; Taylor聽Ayral,聽BS; Alan C.听Hartford,听惭顿; Ashish聽Patel,听惭顿; Seth A.听Rosenthal,听惭顿; Susan聽Chafe,听惭顿; Richard聽Greenberg,听惭顿; Michael A.听Schwartz,听惭顿; Mark E.听Augspurger,听惭顿; John A.听Keech聽Jr,听惭顿; Kathryn A.听Winter,聽MS; Felix Y.听Feng,听惭顿; Jason A.听Efstathiou,听惭顿, DPhil
    Abstract Full Text
    open access
    榴莲视频 Netw Open. 2022; 5(11):e2242378. 10.1001/jamanetworkopen.2022.42378

    This prognostic study evaluates the association of higher normalized MRE11 protein expression with disease-specific mortality among patients undergoing trimodality therapy for muscle-invasive bladder cancer.

  • JAMA Oncology Original Investigation
    March 26, 2020

    Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer

    Robert T.听Dess,听惭顿; Yilun聽Sun,聽PhD; William C.听Jackson,听惭顿; Neil K.听Jairath,聽BS; Amar U.听Kishan,听惭顿; David G.听Wallington,听惭顿; Brandon A.听Mahal,听惭顿; Bradley J.听Stish,听惭顿; Zachery S.听Zumsteg,听惭顿; Robert B.听Den,听惭顿; William A.听Hall,听惭顿; Laila A.听Gharzai,听惭顿; Elizabeth M.听Jaworski,听惭顿; Zachary R.听Reichert,听惭顿, PhD; Todd M.听Morgan,听惭顿; Rohit聽Mehra,听惭顿; Edward M.听Schaeffer,听惭顿; Oliver聽Sartor,听惭顿; Paul L.听Nguyen,听惭顿; William Robert聽Lee,听惭顿; Seth A.听Rosenthal,听惭顿; Jeff M.听Michalski,听惭顿; Matthew J.听Schipper,聽PhD; James J.听Dignam,聽PhD; Thomas M.听Pisansky,听惭顿; Anthony L.听Zietman,听惭顿; Howard M.听Sandler,听惭顿; Jason A.听Efstathiou,听惭顿; Felix Y.听Feng,听惭顿; William U.听Shipley,听惭顿; Daniel E.听Spratt,听惭顿
    Abstract Full Text
    free access
    JAMA Oncol. 2020; 6(5):735-743. 10.1001/jamaoncol.2020.0109

    This secondary analysis examines the association of prostate-specific antigen levels before salvage radiotherapy and net benefit of long-term antiandrogen treatment added to salvage radiotherapy for men with recurrent prostate cancer after radical prostatectomy.

  • JAMA Oncology Original Investigation
    May 10, 2018

    Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features

    William L.听Hwang,听惭顿, PhD; Rahul D.听Tendulkar,听惭顿; Andrzej聽Niemierko,聽PhD; Shree聽Agrawal,聽BS; Kevin L.听Stephans,听惭顿; Daniel E.听Spratt,听惭顿; Jason W.听Hearn,听惭顿; Bridget F.听Koontz,听惭顿; W. Robert聽Lee,听惭顿, MEd, MS; Jeff M.听Michalski,听惭顿; Thomas M.听Pisansky,听惭顿; Stanley L.听Liauw,听惭顿; Matthew C.听Abramowitz,听惭顿; Alan聽Pollack,听惭顿, PhD; Drew聽Moghanaki,听惭顿, MPH; Mitchell S.听Anscher,听惭顿; Robert B.听Den,听惭顿; Anthony L.听Zietman,听惭顿; Andrew J.听Stephenson,听惭顿; Jason A.听Efstathiou,听惭顿, DPhil
    Abstract Full Text
    free access online only
    JAMA Oncol. 2018; 4(5):e175230. 10.1001/jamaoncol.2017.5230

    This multi-institutional cohort study compares adjuvant radiotherapy with early-salvage radiotherapy used to manage postoperative patients with prostate cancer who have adverse pathological features.

  • JAMA Oncology Editorial
    October 1, 2015

    Dose-Escalated Radiotherapy for Prostate Cancer: Is the Sky the Limit?

    Phillip J.听Gray,听惭顿; Anthony L.听Zietman,听惭顿
    Abstract Full Text
    JAMA Oncol. 2015; 1(7):883-884. 10.1001/jamaoncol.2015.2419
  • JAMA Letters
    July 14, 2010

    Conventional and High-Dose Radiation in Treating Early Prostate Cancer鈥擱eply

    James A. Talcott, MD, SM; Anthony L. Zietman, MD
    Abstract Full Text
    JAMA. 2010; 304(2):155-156. 10.1001/jama.2010.928
  • JAMA Original Contribution
    March 17, 2010

    Patient-Reported Long-term Outcomes After Conventional and High-Dose Combined Proton and Photon Radiation for Early Prostate Cancer

    James A. Talcott, MD, SM; Carl Rossi, MD; William U. Shipley, MD; Jack A. Clark, PhD; Jerry D. Slater, MD; Andrzej Niemierko, PhD; Anthony L. Zietman, MD
    Abstract Full Text
    free access
    JAMA. 2010; 303(11):1046-1053. 10.1001/jama.2010.287
  • JAMA Letters
    February 27, 2008

    Correction: Inaccurate Analysis and Results in a Study of Radiation Therapy in Adenocarcinoma of the Prostate

    Anthony L. Zietman, MD
    Abstract Full Text
    JAMA. 2008; 299(8):898-899. 10.1001/jama.299.8.898-c
  • JAMA Original Contribution
    September 14, 2005

    Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate: A Randomized Controlled Trial

    Anthony L. Zietman, MD; Michelle L. DeSilvio, PhD; Jerry D. Slater, MD; Carl J. Rossi, MD; Daniel W. Miller, PhD; Judith A. Adams, MS; William U. Shipley, MD
    Abstract Full Text
    free access
    JAMA. 2005; 294(10):1233-1239. 10.1001/jama.294.10.1233
  • JAMA Original Contribution
    May 5, 1999

    Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-institutional Pooled Analysis

    William U. Shipley, MD; Howard D. Thames, PhD; Howard M. Sandler, MD; Gerald E. Hanks, MD; Anthony L. Zietman, MD; Carlos A. Perez, MD; Deborah A. Kuban, MD; Steven L. Hancock, MD; Cyndi D. Smith
    Abstract Full Text
    free access
    JAMA. 1999; 281(17):1598-1604. 10.1001/jama.281.17.1598